Hydra Biosciences, a leader in the field of Transient Receptor Potential (TRP) channel modulation, today announced that Russell Herndon, President and CEO, will provide a company update at the 17th Annual BIO CEO & Investor Conference in New York City. The presentation is on Feb.10, 2015, at 10:45 a.m. in the Park South room at the Waldorf Astoria hotel.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
